Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linghao Bu

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Endocrinology|April 16, 2025
Primary solitary pituitary stalk abscess: case report and reviewYuehui Ma, Linghao Bu, Jing Jin
Frontiers in Human Neuroscience|March 25, 2021
Intraoperative Cognitive Mapping Tasks for Direct Electrical Stimulation in Clinical and Neuroscientific ContextsLinghao Bu, Junfeng Lu, Jie Zhang, et al.
Scientific Reports|January 13, 2025
Hydrocephalus in primary brainstem hemorrhage risk predictors and managementYuehui Ma, Linghao Bu, Dengchang Wu, et al.
Brain Communications|May 17, 2024
A speech fluency brain network derived from gliomasCechen Sun, Jie Zhang, Linghao Bu, et al.
Brain and Behavior|March 2, 2026
A Language Performance Model for Predicting Glioma Recurrence and Molecular Biomarkers: A Retrospective Cohort StudyHua Song, Linghao Bu, Chen Luo, et al.
Journal of Neuro-Oncology|January 24, 2021
Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastomaLinghao Bu, N U Farrukh Hameed, Chen Luo, et al.
World Neurosurgery|December 28, 2024
Nonenhancing Margin and Pial Invasion in Magnetic Resonance Imaging can Predict Isocitrate Dehydrogenase Status in Glioma PatientsLuhao Yang, Xian Xie, Jie Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2026
Retraction: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent GlioblastomaQingsheng Xu, Kaiyuan Huang, Xiangqi Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2023
Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent GlioblastomaQingsheng Xu, Kaiyuan Huang, Xiangqi Meng, et al.
BMC Cancer|July 9, 2024
Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patientsXian Xie, Chen Luo, Shuai Wu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Endocrinology|April 16, 2025
Primary solitary pituitary stalk abscess: case report and reviewYuehui Ma, Linghao Bu, Jing Jin
Frontiers in Human Neuroscience|March 25, 2021
Intraoperative Cognitive Mapping Tasks for Direct Electrical Stimulation in Clinical and Neuroscientific ContextsLinghao Bu, Junfeng Lu, Jie Zhang, et al.
Scientific Reports|January 13, 2025
Hydrocephalus in primary brainstem hemorrhage risk predictors and managementYuehui Ma, Linghao Bu, Dengchang Wu, et al.
Brain Communications|May 17, 2024
A speech fluency brain network derived from gliomasCechen Sun, Jie Zhang, Linghao Bu, et al.
Brain and Behavior|March 2, 2026
A Language Performance Model for Predicting Glioma Recurrence and Molecular Biomarkers: A Retrospective Cohort StudyHua Song, Linghao Bu, Chen Luo, et al.
Journal of Neuro-Oncology|January 24, 2021
Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastomaLinghao Bu, N U Farrukh Hameed, Chen Luo, et al.
World Neurosurgery|December 28, 2024
Nonenhancing Margin and Pial Invasion in Magnetic Resonance Imaging can Predict Isocitrate Dehydrogenase Status in Glioma PatientsLuhao Yang, Xian Xie, Jie Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2026
Retraction: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent GlioblastomaQingsheng Xu, Kaiyuan Huang, Xiangqi Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2023
Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent GlioblastomaQingsheng Xu, Kaiyuan Huang, Xiangqi Meng, et al.
BMC Cancer|July 9, 2024
Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patientsXian Xie, Chen Luo, Shuai Wu, et al.
Pageof 2